Good potential just needs to demonstrate sales traction
APAS Clinical
- In addition to the US, Thermo Fisher have recently been appointed distributor for the EU market.
- In the latest ********* interview it was suggested further sale/s expected this calendar year. We’ll have to wait and see
APAS Pharma
- Recently received $1.7m development funding from AstraZeneca and Thermo
- Development expected end of this year and sales next year (given AstraZeneca are funding its development would expect they’ll be rolling out across their manufacturing sites - as suggested in that interview)
- In addition to AstraZeneca, APAS being placed with another pharma company
APAS pharma is a new capability - could be very fruitful, but we’ll have to wait and see.
Good potential just needs to demonstrate sales traction APAS...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.89M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $19.94K | 1.200M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1080146 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 292624 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| LBT (ASX) Chart |